TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 06, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, [...] Read more »
Zoom to Release Financial Results for the First Quarter of Fiscal Year 2026
SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the first quarter of fiscal year 2026 on Wednesday, May 21, 2025, [...] Read more »
Zoom Workplace for Frontline now available to improve on-shift communications and work management for frontline workers
SAN JOSE, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Today, Zoom Communications, Inc. (NASDAQ: ZM), announced the launch of Zoom Workplace for Frontline, a purpose–built mobile–first solution that unlocks [...] Read more »
Conditional Issuance of Shares
INSIDE INFORMATION
REGULATED INFORMATION
Conditional Issuance of Shares
Mont–Saint–Guibert, Belgium [...] Read more »
Émission Conditionnelle d’Actions
INFORMATIONS PRIVILÉGIÉES
INFORMATIONS RÉGLEMENTÉES
Émission Conditionnelle d’Actions
Read more »
الرئيس التنفيذي لشركة NeOnc Technologies Holdings, Inc.، Amir Heshmatpour، يتولى دورًا قياديًا مُوسّعًا بصفته الرئيس الجديد للشركة
كالاباساس، كاليفورنيا،, April 10, 2025 (GLOBE NEWSWIRE) — [...] Read more »
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President
CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical–stage biopharmaceutical company focused on innovative treatments for central [...] Read more »
Nyxoah Provides Update on FDA Approvable Letter for Genio System
Nyxoah Provides Update on FDA Approvable Letter for Genio System
Expects to meet final FDA requirements for full PMA approval in the second quarter
Read more »
Nyxoah Présente une Mise à Jour Concernant la Lettre d'Approuvabilité de la FDA pour le Système Genio
Nyxoah Présente une Mise à Jour Concernant la Lettre d'Approuvabilité de la FDA pour le Système Genio
Prévoit de satisfaire aux exigences finales de la FDA pour [...] Read more »
Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates
JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business [...] Read more »
Lantronix lance le nouveau System on module Open-Q 8550CS conçu pour répondre aux besoins de l’IA en périphérie du réseau
IRVINE, Californie, 28 mars 2025 (GLOBE NEWSWIRE) — Read more »
Lantronix bringt neues Open-Q 8550CS System-On-Module auf den Markt, das die Anforderungen von Edge-KI-Computing optimal erfüllt
IRVINE, Kalifornien, March 28, 2025 (GLOBE NEWSWIRE) — Read more »
Lantronix Lança Novo System-On-Module Open-Q 8550CS Projetado para Atender às Necessidades de Edge AI Computing
IRVINE, Califórnia, March 27, 2025 (GLOBE NEWSWIRE) — A Read more »
Lantronix Launches New Open-Q 8550CS System-On-Module Designed to Meet the Needs of Edge AI Computing
IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) — Read more »
La FDA Délivre à Nyxoah une Lettre d'Approuvabilité pour son système Genio®
INFORMATIONS PRIVILÉGIÉES
INFORMATIONS RÉGLEMENTÉES
La FDA Délivre à Nyxoah une Lettre [...] Read more »